JULIE BIGHOUSE: Open Payments
NPI 1720075591 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$797 in 44 payments from 16 companies in 2025. Trend: 2023 $537 · 2024 $850 · 2025 $797
Food & beverage: $797
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 11 | $172 |
| E.R. Squibb & Sons, L.L.C. | 6 | $99 |
| Merck Sharp & Dohme LLC | 5 | $99 |
| Amgen Inc. | 4 | $61 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $51 |
| Esperion Therapeutics, Inc. | 3 | $50 |
| SCPHARMACEUTICALS INC. | 3 | $44 |
| PFIZER INC. | 2 | $38 |
| Alnylam Pharmaceuticals Inc. | 1 | $33 |
| AstraZeneca Pharmaceuticals LP | 1 | $31 |
Products named: LEQVIO, CAMZYOS, VERQUVO, REPATHA, LifeVest, NEXLETOL, FUROSCIX, ONPATTRO.
Industry payments across TX — which companies pay providers there.
